Plasmo
PrivateCompany Overview
Plasmo is a software development company that provides an open-source framework and platform for building, testing, and deploying browser extensions.
Sector
AI, Data & Cloud Infrastructure
Verticals
DevOps & Containers, Platform-as-a-Service, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plasmo Comparables
Compare Plasmo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WXT | 83% | |
| Craft.js | 77% | |
| CRXJS | 77% |
Plasmo Funding Rounds
Historical fundraising activity
Plasmo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Plasmo's valuation, stock price, and market status.
Is Plasmo a public or private company?
Plasmo is a private company.
What is the current stock price of Plasmo?
Plasmo is a private company, so its shares have no public market price. Caplight tracks Plasmo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Plasmo worth (valuation)?
Valuation information for Plasmo is not publicly available.
Can I buy Plasmo stock?
Plasmo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Plasmo's last funding round?
Funding round information for Plasmo is not publicly available.
Who are the main investors in Plasmo?
Investor information for Plasmo is not publicly disclosed.
Will Plasmo IPO soon?
No public IPO plans have been announced for Plasmo.
How can I track Plasmo secondary market activity?
Caplight tracks bids, offers, and trades in Plasmo's shares on secondary markets.